Showing results (251-260 of 1,819) with videos related to
Sort By:
Pageof 182
Journal of Addiction Medicine|September 14, 2020
Posttraumatic Stress Disorder After a Psychedelic Experience, a Case ReportDafna Sara Rubin-Kahana, Ahmed Nabeel Hassan, Bernard Le FollJournal of Addiction Medicine|September 14, 2020
Using Extended Release Buprenorphine Injection to Discontinue Sublingual Buprenorphine: A Case SeriesAlexis D Ritvo, Susan L Calcaterra, Jonathan I RitvoJournal of Addiction Medicine|August 28, 2020
A Case Report of Isopropanol Ingestion During the SARS-CoV-2 PandemicCaroline P Meehan, Rachel S WightmanJournal of Addiction Medicine|October 8, 2020
Naloxone Use by Emergency Medical Services During the COVID-19 Pandemic: A National SurveyDavid C Cone, Sandy Bogucki, Kevin Burns, et al.Journal of Addiction Medicine|October 8, 2020
Impact of COVID-19 Related Policy Changes on Buprenorphine Dispensing in TexasJames Douglas Thornton, Tyler J Varisco, Shweta S Bapat, et al.Journal of Addiction Medicine|February 13, 2019
Adverse Events During Treatment Induction With Injectable Diacetylmorphine and Hydromorphone for Opioid Use DisorderEugenia Oviedo-Joekes, Heather Palis, Daphne Guh, et al.Journal of Addiction Medicine|November 12, 2020
A Case of False-positive Amphetamine Results on Urine Toxicology Testing Secondary to ImatinibSarah Meyers, Elisha M WachmanJournal of Addiction Medicine|March 19, 2020
Associations Among Childhood Household Dysfunction, Sexual Orientation, and DSM-5 Alcohol, Tobacco and Other Substance Use Disorders in Adulthood: Evidence From a National U.S. SurveySean Esteban McCabe, Tonda L Hughes, Brady T West, et al.Journal of Addiction Medicine|March 7, 2020
Case Study: Naltrexone for the Treatment of Nitrous Oxide UseSarah Ickowicz, Rupinder Brar, Seonaid NolanJournal of Addiction Medicine|March 7, 2020
Factors Associated With the Use of Supervised Consumption Facilities Among Women Who Inject Drugs in a Canadian SettingSarah Ickowicz, Cameron Grant, Ekaterina Nosova, et al.Pageof 182